Table 5 Antimicrobial resistance profiles of Gram negative isolates from external ocular infections at Felege Hiwot Referral Hospital, 2019
Antimicrobials | K. pneumoniae (n = 28) | Proteus spp., (n = 15) | P.aeruginosa (n = 6) | E. coli (n = 5) | Enterobacter spp., (n = 5) | Citrobacter spp (n = 9) | K.rinoscleromatis (n = 2) | Total (n = 64) |
|---|---|---|---|---|---|---|---|---|
R% | R% | R% | R% | R% | R% | R% | R% | |
Ampicillin | 28 (100) | 14 (93.3) | NA | 0 | 4 (80) | 8 (88.9) | 2 (100) | 56 (87.5) |
Amoxacillin-clavulanic acid | 3 (12.1) | 7 (46.7) | NA | 1 (20) | 5 (100) | 2 (22.2) | 0 | 18 (28.1) |
Ciprofloxacin | 3 (10.8) | 1 (6.7) | 2 (33.3) | 0 | 1 (20) | 1 (11.2) | 0 | 8 (11.4) |
Trimethprim-Sulfamethozazole | 13 (46.5) | 5 (33.3) | NA | 1 (20) | 0 | 0 | 1 (50) | 20 (31.3) |
Tetracycline | 17 (60.7) | 4 (26.6) | NA | 5(100) | 2 (40) | 6 (66.7) | 2 (100) | 36 (56.3) |
Gentamycin | 4 (14.3) | 4 (14.3) | 3 (50) | 1(20) | 1 (20) | 2 (22.2) | 0 | 15 (21.4) |
Ceftazidime | NA | NA | 2 (33.3) | NA | NA | NA | NA | 2 (33.3) |
Piperacillin | NA | NA | 5 (83.3 | NA | NA | NA | NA | 5 (83.3) |
Tobramycin | NA | NA | 3 (50) | NA | NA | NA | NA | 3 (50) |
Total | 68/150 (40.5) | 35/90 (38.9) | 15/30 (50) | 8/30 (26.7) | 13/30 (43.3) | 19/54 (35.2) | 5/12 (41.7) | 163/396 (41.2) |